Portfolio Changes: Crestline Management, LP Q3 2022 vs. Q4 2022

Crestline Management, LP Q3 2022 vs. Q4 2022 13F Holdings Comparison

Crestline Management, LP has made a few changes in its holdings in the third quarter of 2022 compared to the fourth quarter of 2022. This article will explore Crestline Management's portfolio changes and analyze the stocks it has added to or reduced its position in.

The data from the 13F filing of Crestline Management, LP shows that it has reduced its position in some companies and added others. The company has reduced its position in American International Group Inc (AIG), NCR Corp New (NCR), and United Therapeutics Corp Del (UTHR) by 13.2%, 49.3%, and 2.3%, respectively.

On the other hand, Crestline Management, LP has increased its position in Broadcom Inc (AVGO), Analog Devices Inc (ADI), and Truist Finl Corp (TFC) by 91.6%, 347.5%, and 129.2%, respectively.

Below is a breakdown of the notable changes in Crestline Management's portfolio:

Broadcom Inc (AVGO)

Crestline Management has increased its position in Broadcom Inc (AVGO) by 91.6% from 18,424 shares to 28,033 shares. Broadcom is a leading supplier of semiconductor solutions for wired and wireless communications.

Analog Devices Inc (ADI)

Crestline Management has increased its position in Analog Devices Inc (ADI) by 347.5% from 19,864 shares to 75,523 shares. Analog Devices is a leading global manufacturer of analog, mixed-signal, and digital signal processing integrated circuits used in various applications.

Truist Finl Corp (TFC)

Crestline Management has increased its position in Truist Finl Corp (TFC) by 129.2% from 100,000 shares to 172,082 shares. Truist is a bank holding company that provides banking services to individuals and businesses.

American International Group Inc (AIG)

Crestline Management has reduced its position in American International Group Inc (AIG) by 13.2% from 10,000 shares to 17,082 shares. AIG is a leading global insurance company that provides property, casualty, and life insurance.

NCR Corp New (NCR)

Crestline Management has reduced its position in NCR Corp New (NCR) by 49.3% from 504,459 shares to 611,748 shares. NCR is a leading provider of omni-channel solutions, turning everyday interactions with businesses into exceptional experiences.

United Therapeutics Corp Del (UTHR)

Crestline Management has reduced its position in United Therapeutics Corp Del (UTHR) by 2.3% from 12,181 shares to 12,306 shares. United Therapeutics is a biotechnology company focused on the development and commercialization of innovative products for patients with chronic and life-threatening diseases.

Conclusion

In conclusion, Crestline Management, LP has made some notable changes in its portfolio in the third quarter of 2022. The company has increased its position in Broadcom Inc (AVGO), Analog Devices Inc (ADI), and Truist Finl Corp (TFC) while reducing its position in American International Group Inc (AIG), NCR Corp New (NCR), and United Therapeutics Corp Del (UTHR). Investors should keep an eye on Crestline Management's future moves to gain insight into the company's investment strategy.